Pfizer and Moderna to fight Omicron

Pharmaceutical giants Pfizer and Moderna have started clinical trials for a COVID-19 vaccine specifically designed to target the Omicron variant. The moves are part of a larger conversation about whether we will need variant-specific COVID-19 vaccines as time goes on. The Progressive Health Forum’s Aslam Dasoo has more. Courtesy #DStv403

Source
eNCA

Paid Content